Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.
2.

Dilemmas in medical ethics in the age of big data.

Ludwin SK, Murray TJ.

Mult Scler. 2017 Sep;23(10):1306-1308. doi: 10.1177/1352458517722056. Epub 2017 Jul 26. No abstract available.

PMID:
28743225
3.

Serving two masters: the medical and political careers of Sir Charles Tupper.

Murray TJ.

CMAJ. 2017 Jun 26;189(25):E866-E868. doi: 10.1503/cmaj.170224. No abstract available.

4.

Escalating MS drug costs in the US: Puzzling, troubling, and suspicious.

Murray TJ, Brown MG.

Neurology. 2015 May 26;84(21):2105-6. doi: 10.1212/WNL.0000000000001624. Epub 2015 Apr 24. No abstract available.

PMID:
25911109
5.

MS trailblazer on the art of medicine.

Murray TJ, Vogel L.

CMAJ. 2015 Feb 17;187(3):E87-8. doi: 10.1503/cmaj.109-4971. Epub 2015 Jan 12. No abstract available.

6.

Estimating typical multiple sclerosis disability progression speed from clinical observations.

Brown MG, Asbridge M, Hicks V, Kirby S, Murray TJ, Andreou P, Lin D.

PLoS One. 2014 Oct 17;9(10):e105123. doi: 10.1371/journal.pone.0105123. eCollection 2014.

7.

Prenatal exposure to BPA alters the epigenome of the rat mammary gland and increases the propensity to neoplastic development.

Dhimolea E, Wadia PR, Murray TJ, Settles ML, Treitman JD, Sonnenschein C, Shioda T, Soto AM.

PLoS One. 2014 Jul 2;9(7):e99800. doi: 10.1371/journal.pone.0099800. eCollection 2014.

8.

Hand dexterity and direct disease related cost in multiple sclerosis.

Koch MW, Murray TJ, Fisk J, Greenfield J, Bhan V, Jacobs P, Brown M, Metz LM.

J Neurol Sci. 2014 Jun 15;341(1-2):51-4. doi: 10.1016/j.jns.2014.03.047. Epub 2014 Apr 2.

PMID:
24768310
9.

Interactive direct and plant-mediated effects of elevated atmospheric [CO2 ] and temperature on a eucalypt-feeding insect herbivore.

Murray TJ, Ellsworth DS, Tissue DT, Riegler M.

Glob Chang Biol. 2013 May;19(5):1407-16. doi: 10.1111/gcb.12142. Epub 2013 Feb 11.

PMID:
23504696
10.

Neurology in Canada: history of the Canadian Neurological Society.

Murray TJ, Bray G, Freedman M, Stoessl AJ.

Neurology. 2013 Jan 22;80(4):406-8. doi: 10.1212/WNL.0b013e31827f0788. No abstract available.

11.

Interactive effects of pre-industrial, current and future [CO2] and temperature on an insect herbivore of Eucalyptus.

Murray TJ, Tissue DT, Ellsworth DS, Riegler M.

Oecologia. 2013 Apr;171(4):1025-35. doi: 10.1007/s00442-012-2467-9. Epub 2012 Oct 2.

PMID:
23053228
12.

Russell Brains Review of MS.

Murray T.

Int MS J. 2011 May;17(2):50-3. Review.

PMID:
21689497
13.

Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation.

Veugelers PJ, Fisk JD, Brown MG, Stadnyk K, Sketris IS, Murray TJ, Bhan V.

Mult Scler. 2009 Nov;15(11):1286-94. doi: 10.1177/1352458509350307. Epub 2009 Oct 30.

PMID:
19965558
14.

Robert Carswell: the first illustrator of MS.

Murray TJ.

Int MS J. 2009 Sep;16(3):98-101.

PMID:
19878632
15.

Read any good books lately?

Murray TJ.

Mcgill J Med. 2009 Jan;12(1):90-1. No abstract available.

16.

Histological analysis of low dose NMU effects in the rat mammary gland.

Murray TJ, Ucci AA, Maffini MV, Sonnenschein C, Soto AM.

BMC Cancer. 2009 Aug 3;9:267. doi: 10.1186/1471-2407-9-267.

17.

Parent-of-origin effect in multiple sclerosis: observations from interracial matings.

Ramagopalan SV, Yee IM, Dyment DA, Orton SM, Marrie RA, Sadovnick AD, Ebers GC; Canadian Collaborative Study Group.

Neurology. 2009 Aug 25;73(8):602-5. doi: 10.1212/WNL.0b013e3181af33cf. Epub 2009 Jun 10.

18.

Association of infectious mononucleosis with multiple sclerosis. A population-based study.

Ramagopalan SV, Valdar W, Dyment DA, DeLuca GC, Yee IM, Giovannoni G, Ebers GC, Sadovnick AD; Canadian Collaborative Study Group.

Neuroepidemiology. 2009;32(4):257-62. doi: 10.1159/000201564. Epub 2009 Feb 11.

PMID:
19209005
19.

The history of multiple sclerosis: the changing frame of the disease over the centuries.

Murray TJ.

J Neurol Sci. 2009 Feb 1;277 Suppl 1:S3-8. doi: 10.1016/S0022-510X(09)70003-6. Review.

PMID:
19200863
20.

Age of puberty and the risk of multiple sclerosis: a population based study.

Ramagopalan SV, Valdar W, Criscuoli M, DeLuca GC, Dyment DA, Orton SM, Yee IM, Ebers GC, Sadovnick AD; Canadian Collaborative Study Group.

Eur J Neurol. 2009 Mar;16(3):342-7. doi: 10.1111/j.1468-1331.2008.02431.x.

PMID:
19170744
21.

Faria's disease, a fictional character in search of a diagnosis.

Murray TJ.

Pract Neurol. 2008 Dec;8(6):378-80. doi: 10.1136/jnnp.2008.156885. No abstract available.

PMID:
19015298
22.

The 'Ethereal' nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics.

Bazin HG, Murray TJ, Bowen WS, Mozaffarian A, Fling SP, Bess LS, Livesay MT, Arnold JS, Johnson CL, Ryter KT, Cluff CW, Evans JT, Johnson DA.

Bioorg Med Chem Lett. 2008 Oct 15;18(20):5350-4. doi: 10.1016/j.bmcl.2008.09.060. Epub 2008 Sep 19.

PMID:
18835160
23.

How effective are disease-modifying drugs in delaying progression in relapsing-onset ms?

Brenner SR, Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS.

Neurology. 2008 Aug 19;71(8):615; author reply 615-6. doi: 10.1212/01.wnl.0000324708.37575.5c. No abstract available.

PMID:
18711118
24.

Total synthesis of GEX1A.

Murray TJ, Forsyth CJ.

Org Lett. 2008 Aug 21;10(16):3429-31. doi: 10.1021/ol800902g. Epub 2008 Jul 19.

PMID:
18642829
25.

Efficacy and tolerability of intramuscular interferon beta-1a compared with subcutaneous interferon beta-1a in relapsing MS: results from PROOF.

Minagara A, Murray TJ; PROOF Study Investigators.

Curr Med Res Opin. 2008 Apr;24(4):1049-55. doi: 10.1185/030079908X280545 . Epub 2008 Feb 29.

PMID:
18315940
26.

The Halifax Explosion of 1917: the oculist experience.

McAlister CN, Murray TJ, Maxner CE.

Can J Ophthalmol. 2008 Feb;43(1):27-32. doi: 10.3129/i07-218.

PMID:
18219344
27.

Human fetal testis Leydig cell disruption by exposure to the pesticide dieldrin at low concentrations.

Fowler PA, Abramovich DR, Haites NE, Cash P, Groome NP, Al-Qahtani A, Murray TJ, Lea RG.

Hum Reprod. 2007 Nov;22(11):2919-27. Epub 2007 Sep 11.

PMID:
17848404
28.

How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?

Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS.

Neurology. 2007 Oct 9;69(15):1498-507. Epub 2007 Aug 15.

PMID:
17699802
29.

The Halifax disaster (1917): eye injuries and their care.

McAlister CN, Murray TJ, Lakosha H, Maxner CE.

Br J Ophthalmol. 2007 Jun;91(6):832-5.

30.

ALS incidence in Nova Scotia over a 20-year-period: a prospective study.

Bonaparte JP, Grant IA, Benstead TJ, Murray TJ, Smith M.

Can J Neurol Sci. 2007 Feb;34(1):69-73.

PMID:
17352350
31.

Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure.

Murray TJ, Maffini MV, Ucci AA, Sonnenschein C, Soto AM.

Reprod Toxicol. 2007 Apr-May;23(3):383-90. Epub 2006 Oct 24.

33.

Diagnosis and treatment of multiple sclerosis.

Murray TJ.

BMJ. 2006 Mar 4;332(7540):525-7. Review. No abstract available.

34.

The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?

Murray TJ.

Expert Opin Drug Saf. 2006 Mar;5(2):265-74. Review.

PMID:
16503747
35.

IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.

Kinkel RP, Kollman C, O'Connor P, Murray TJ, Simon J, Arnold D, Bakshi R, Weinstock-Gutman B, Brod S, Cooper J, Duquette P, Eggenberger E, Felton W, Fox R, Freedman M, Galetta S, Goodman A, Guarnaccia J, Hashimoto S, Horowitz S, Javerbaum J, Kasper L, Kaufman M, Kerson L, Mass M, Rammohan K, Reiss M, Rolak L, Rose J, Scott T, Selhorst J, Shin R, Smith C, Stuart W, Thurston S, Wall M; CHAMPIONS Study Group.

Neurology. 2006 Mar 14;66(5):678-84. Epub 2006 Jan 25.

PMID:
16436649
36.

Complementary and alternative medicine for MS.

Murray TJ.

Int MS J. 2006 Jan;13(1):3.

PMID:
16420778
37.
38.

The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells.

Yang X, Liu D, Murray TJ, Mitchell GC, Hesterman EV, Karchner SI, Merson RR, Hahn ME, Sherr DH.

Oncogene. 2005 Nov 24;24(53):7869-81.

PMID:
16091746
39.

Treating fatigue in patients with MS: one step forward, one step back.

Schwid SR, Murray TJ.

Neurology. 2005 Apr 12;64(7):1111-2. No abstract available.

PMID:
15824329
40.

Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS study.

Freedman MS, Francis GS, Sanders EA, Rice GP, O'Connor P, Comi G, Duquette P, Metz L, Murray TJ, Bouchard JP, Abramsky O, Pelletier J, O'Brien F; Once Weekly Interferon beta-1alpha for Multiple Sclerosis Study Group; University of British Columbia MS/MRI Research Group.

Mult Scler. 2005 Feb;11(1):41-5.

PMID:
15732265
41.

A comparison of health utility measures for the evaluation of multiple sclerosis treatments.

Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ.

J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):58-63.

42.

Strategies for managing the side effects of treatments for multiple sclerosis.

Langer-Gould A, Moses HH, Murray TJ.

Neurology. 2004 Dec 14;63(11 Suppl 5):S35-41. Review.

PMID:
15596735
43.

Timing of birth and risk of multiple sclerosis: population based study.

Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC; Canadian Collaborative Study Group.

BMJ. 2005 Jan 15;330(7483):120. Epub 2004 Dec 7.

44.

A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosis.

Phillips JT, Rice G, Frohman E, Vande Gaer L, Scott T, Haas J, Eggenberger E, Freedman MS, Stuart W, Cunha L, Jacobs L, Oger J, Arnold D, Murray TJ, DiBiase M, Jethwa V, Goelz S.

Clin Ther. 2004 Apr;26(4):511-21.

PMID:
15189748
45.

Patterns of cannabis use among patients with multiple sclerosis.

Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME.

Neurology. 2004 Jun 8;62(11):2098-100.

PMID:
15184623
47.

Identical twins discordant for multiple sclerosis have a shift in their T-cell receptor repertoires.

Haegert DG, Galutira D, Murray TJ, O'Connor P, Gadag V.

Clin Exp Immunol. 2003 Dec;134(3):532-7.

48.

Mitoxantrone slowed progression of disability and reduced relapses in multiple sclerosis.

Murray TJ.

ACP J Club. 2003 Sep-Oct;139(2):45. No abstract available.

PMID:
12954037
49.

Samuel Johnson: his ills, his pills and his physician friends.

Murray TJ.

Clin Med (Lond). 2003 Jul-Aug;3(4):368-72.

PMID:
12938754
50.

Short term predictors of unemployment in multiple sclerosis patients.

Busche KD, Fisk JD, Murray TJ, Metz LM.

Can J Neurol Sci. 2003 May;30(2):137-42.

PMID:
12774953

Supplemental Content

Loading ...
Support Center